H.I.G. Capital accomplished a number of transactions in June that underscore the Miami-based funding agency’s give attention to healthcare companies and European market growth, whereas additionally divesting non-core property from portfolio firms.
The $70 billion different funding agency added veteran non-public fairness skilled Antonin Marcus as a managing director in its Paris workplace, marking a return to H.I.G. for Marcus after an eight-year stint at Eurazeo. Marcus beforehand labored at H.I.G. earlier in his profession and commenced at Goldman Sachs in London.
“Antonin is a extremely regarded non-public fairness investor,” stated Olivier Boyadjian, managing director and head of H.I.G.’s Paris workplace. Marcus will lead center market LBO actions in France, complementing the agency’s present European capabilities.
H.I.G. additionally completed the acquisition of ITH Group Restricted, a UK supplier of aseptic pharmaceutical compounding companies, partnering with founders Adam Bloom and Karen Hamling. ITH prepares injectable medicines for sufferers with specialised medical wants, holding market-leading positions in chemotherapy, whole parenteral diet and central intravenous additive companies.
The corporate, which operates services in London, serves each NHS and personal healthcare channels. Since its 2008 founding, ITH has maintained constant development by investing in personnel and increasing service choices to handle undersupplied market segments.
“The Firm’s monitor report of reliably offering compounded prescription drugs to NHS and personal prospects in an inherently undersupplied market, mixed with H.I.G.’s historical past of supporting capability growth in its portfolio firms, underpins an thrilling subsequent chapter for ITH,” stated John Harper, managing director and head of H.I.G.’s Europe Decrease Center Market LBO group.
In the meantime, H.I.G. portfolio firm Highridge Medical divested its EBI Bone Therapeutic Division to Avista Healthcare Companions. H.I.G. had acquired EBI as a part of Highridge’s take-private transaction in April 2024. The Parsippany, New Jersey-based division gives non-invasive bone stimulation units for spinal and orthopedic sufferers.
The divestiture permits Highridge to pay attention sources on core backbone options and surgical expertise innovation. H.I.G. had invested in new management and expanded product growth capabilities at EBI following the preliminary acquisition.
“This transaction permits us to make vital investments in Highridge’s core backbone enterprise, the place we see large alternatives to guide the following technology of backbone care,” stated Mike Gallagher, managing director at H.I.G.
H.I.G. Capital operates 19 workplaces globally and has invested in additional than 400 firms since its 1993 founding. The agency’s present portfolio contains over 100 firms with mixed gross sales exceeding $53 billion.
